Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHays Regulatory News (HAS)

Share Price Information for Hays (HAS)

Share Price is delayed by 15 minutes
Get Live Data
35.46    1.22 (3.56%)
Bid:
35.36
Ask:
35.54
Spread: 0.18 (0.509%)
Market Cap: £567.01m
HAS Live PriceLast checked at - London Stock Exchange

Intraday Hays Share Chart

Director/PDMR Shareholding

23 Sep 2011 15:34

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

Hays plc (the "Company")

In accordance with DTR 3.1.4(R)(1)(a) the Company hereby notifies you of the following changes in the interests of directors and persons discharging managerial responsibility ("PDMRs") arising out of the grant of conditional awards of Ordinary shares in the Company ("Shares") under the Performance Share Plan.

PERFORMANCE SHARE PLAN ("PSP")

Today, 23 September 2011, the following conditional awards of Shares were granted for nil consideration to PDMRs under the rules of the PSP. The number of Shares under award was calculated by reference to the price of 70.9 pence per Share, being the closing middle market price on 22 September 2011. The number of Shares stated below is the maximum number of Shares available to each PDMR on satisfaction in full of the applicable performance conditions.

DIRECTOR NUMBER OF SHARESNAME OR PDMR UNDER PSP AWARDAlistair Cox Director & PDMR 1,601,657Paul Venables Director & PDMR 1,154,795Tim Cook PDMR 479,407Nick Cox PDMR 552,572James Cullens PDMR 418,392Sholto Douglas-Home PDMR 348,660Nigel Heap PDMR 846,789Royston Hoggarth PDMR 550,070Stephen Weston PDMR 479,407Alison Yapp PDMR 387,588TOTAL SHARES 6,819,337

The vesting of one-half of the Shares under award will depend on the Company's total shareholder return performance relative to a sector peer group, measured over the three-year period to 30 June 2014. Vesting of this tranche will also be dependent on the Remuneration Committee being satisfied with the financial performance of the Company over the three-year period. The vesting of the remaining one-half of the Shares under award will depend on achievement of a target based on the Group's cumulative Earnings per Share ("EPS") performance over the three financial years from 1 July 2011 to 30 June 2014. The lower and upper EPS growth range for the first year of the cycle, from 1 July 2011 to 30 June 2012, will be based on external consensus forecasts for that year (being a range of +/- 4% around the consensus forecast EPS of 6.22p per share). The EPS growth for the remaining two years of the cycle from 1 July 2012 to 30 June 2014 will require additional growth of between RPI+4% and RPI+12% per annum to achieve threshold and maximum vesting respectively. This approach was adopted following discussion with major shareholders in 2010. Further information will be set out in the Company's 2011 Remuneration Report to be published in September 2011.

For further information in respect of this announcement please contact Neil Tsappis, Deputy Company Secretary, Hays plc on +44 (0) 20 7383 2266.

23 September 2011

PINX
Date   Source Headline
4th Jun 20262:18 pmRNSDirector/PDMR Shareholding
1st Jun 202611:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSShare buyback programme
27th May 20269:14 amRNSHolding(s) in Company
19th May 20265:00 pmRNSDirector/PDMR Shareholding
18th May 20267:05 amRNSDirector/PDMR Shareholding
18th May 20267:00 amRNSCEO Appointment
1st May 202610:00 amRNSTotal Voting Rights
29th Apr 20264:06 pmRNSDirector/PDMR Shareholding
28th Apr 20269:59 amRNSDirector/PDMR Shareholding
22nd Apr 20262:09 pmRNSHolding(s) in Company
22nd Apr 20262:06 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSThird Quarter Trading Statement
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
1st Apr 202611:00 amRNSTotal Voting Rights
27th Mar 20265:00 pmRNSHolding(s) in Company
27th Mar 20264:11 pmRNSDirector/PDMR Shareholding
25th Mar 202610:05 amRNSDirector/PDMR Shareholding
4th Mar 20261:24 pmRNSDirector/PDMR Shareholding
3rd Mar 20264:08 pmRNSDirector/PDMR Shareholding
2nd Mar 20263:00 pmRNSDirector/PDMR Shareholding
2nd Mar 202611:00 amRNSTotal Voting Rights
27th Feb 20264:15 pmRNSHolding(s) in Company
27th Feb 20267:01 amRNSCEO departure and succession plan
27th Feb 20267:00 amRNSHalf-Year Report
2nd Feb 202611:00 amRNSTotal Voting Rights
14th Jan 20267:00 amRNSSecond Quarter Trading Statement
5th Jan 20267:00 amRNSCEO update
2nd Jan 202610:00 amRNSTotal Voting Rights
1st Dec 202511:00 amRNSTotal Voting Rights
21st Nov 20253:10 pmRNSDirector/PDMR Shareholding
19th Nov 20252:33 pmRNSResult of AGM
11th Nov 202512:00 pmRNSDirector/PDMR Shareholding
10th Nov 20257:00 amRNSCEO Medical Leave
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 202510:00 amRNSTotal Voting Rights
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 202511:00 amRNSShare buyback programme
10th Oct 20257:00 amRNSFirst Quarter Trading Statement
6th Oct 202512:00 pmRNSPublication of Annual Report and Notice of AGM
3rd Oct 202511:09 amRNSDirector/PDMR Shareholding
1st Oct 202510:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.